Source link : https://www.newshealth.biz/health-news/big-prevention-benefits-with-daratumumab/
SAN DIEGO — The multiple myeloma (MM) drug daratumumab (Darzalex), an anti-CD38 monoclonal antibody, dramatically reduced progression to active MM or death in patients with high-risk smoldering MM (SMM), a landmark randomized, open-label, phase 3 study found. Among 390 patients with SMM (194 assigned to daratumumab and 196 to active monitoring), progression to active MM […]
Author : News Health
Publish date : 2024-12-16 10:57:58
Copyright for syndicated content belongs to the linked Source.
inHealth